V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004090 | 290003028 | 1.62 | 91 | Curative (C) | 2014-12-11 | 2014-12-11 | LANREOTIDE | 2 | null | 290020553 | OCTREOTIDE |
| 290004091 | 290003029 | 1.51 | null | Palliative (P) | 2016-07-26 | 2016-07-26 | Capecitabine + Cisplatin | 2 | N | 290020554 | EOX |
| 290004092 | 290003030 | null | null | Neo-adjuvant (N) | 2016-12-01 | 2016-12-19 | CARBOPLATIN | null | Y | 290020555 | LANREOTIDE |
| 290004093 | 290003031 | 1.68 | 47 | Palliative (P) | 2018-08-20 | 2018-08-20 | CISPLATIN + ETOPOSIDE | 02 | N | 290020556 | GEMCARBO |
| 290004094 | 290003032 | 1.75 | null | null | 2014-11-27 | 2014-12-02 | OCTREOTIDE | N | N | 290020559 | OCTREOTIDE |
| 290004095 | 290003033 | 1.75 | null | Curative (C) | 2015-08-25 | 2015-08-27 | Capecitabine | 02 | null | 290020560 | CAPECITABINE + CARBOPLATIN |
| 290004097 | 290003035 | 1.62 | 53 | null | 2013-02-12 | 2013-02-26 | Capecitabine 35days + RT | 02 | Y | 290020563 | MITOMYCIN INTRAVESICULAR |
| 290004098 | 290003035 | 1.68 | null | Neo-adjuvant (N) | 2014-07-18 | 2014-07-19 | Fluorouracil + Folinic Acid Weekly | Y | N | 290020563 | CAPECITABINE + CARBOPLATIN |
| 290004099 | 290003035 | null | null | Neo-adjuvant (N) | 2017-08-18 | 2017-08-22 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 290020563 | GEMCITABINE |
| 290004100 | 290003036 | 1.6 | 52.6 | Palliative (P) | 2015-04-09 | 2015-04-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 290020568 | GEMCITABINE |
| 290004101 | 290006413 | 1.6 | 51.1 | Palliative (P) | 2014-04-14 | 2014-04-28 | OCTREOTIDE | 02 | null | 290020571 | CAPECITABINE + RT |
| 290004102 | 290006413 | null | 74.2 | Adjuvant (A) | 2014-06-01 | 2014-06-08 | Mitomycin Intravesical | null | N | 290020571 | CAPECITABINE + TEMOZOLOMIDE |
| 290004103 | 290003037 | 1.65 | 73 | Curative (C) | 2018-01-17 | 2018-01-20 | Capecitabine 35days + RT | 02 | null | 290020573 | CETUXIMAB + RT |
| 290004104 | 290003037 | 1.64 | 74.2 | Palliative (P) | null | 2016-05-25 | CISPLATIN + FLUOROURACIL | null | N | 290020573 | CARBOPLATIN + ETOPOSIDE |
| 290004105 | 290003038 | 1.56 | 63 | Curative (C) | 2017-08-31 | 2017-09-02 | CARBOPLATIN + RT | 2 | Y | 290020576 | TRIAL |
| 290004106 | 290003039 | 1.82 | 97.8 | Neo-adjuvant (N) | 2016-08-20 | 2016-08-20 | Capecitabine | 02 | N | 290020577 | LANREOTIDE |
| 290004107 | 290003040 | 1.63 | null | Palliative (P) | null | 2017-03-23 | Capecitabine + Cisplatin | N | N | 290020580 | GEMCITABINE |
| 290004108 | 290003040 | 1.68 | 59.7 | Adjuvant (A) | 2014-11-13 | 2014-11-13 | Capecitabine | 2 | null | 290020580 | CAPECITABINE |
| 290004109 | 290003041 | 1.98 | null | Palliative (P) | 2016-06-13 | 2016-06-24 | Capecitabine | N | N | 290020583 | TRIAL |
| 290004110 | 290003041 | 1.82 | 111 | Not known (9) | 2015-01-29 | 2015-02-26 | Folfirinox | Y | Y | 290020583 | CISPLATIN + PEMETREXED |
| 290004111 | 290003042 | 1.48 | null | Palliative (P) | 2016-03-16 | 2016-03-19 | CISPLATIN + FLUOROURACIL | 2 | N | 290020590 | CAPECITABINE |
| 290004112 | 290003043 | null | 64 | Curative (C) | null | 2015-01-24 | Fluorouracil + Folinic Acid Weekly | N | Y | 290020592 | CAPECITABINE |
| 290004113 | 290003044 | null | 64.2 | Palliative (P) | 2017-10-07 | 2017-10-09 | CARBOPLATIN + ETOPOSIDE | 02 | null | 290020595 | IPILIMUMAB |
| 290004114 | 290003045 | 0 | 0 | null | 2016-06-12 | 2016-06-14 | Cetuximab 7 day (Cycle 1) | 2 | N | 290020596 | CISPLATIN + ETOPOSIDE |
| 290004115 | 290003046 | 1.7 | 82.5 | Disease modification (D) | 2016-06-11 | 2016-06-11 | LANREOTIDE | N | N | 290020597 | NOT MATCHED |
| 290004116 | 290003047 | 1.55 | null | Palliative (P) | 2016-04-07 | 2016-04-19 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 290020599 | CAPECITABINE + RT |
| 290004117 | 290003048 | null | null | Curative (C) | 2016-01-12 | 2016-01-17 | Capecitabine 35days + RT | 2 | N | 290020601 | TRIAL |
| 290004118 | 290003048 | 1.82 | 74.3 | Neo-adjuvant (N) | 2014-10-28 | 2014-11-04 | PLATO Trials | N | N | 290020601 | IPILIMUMAB |
| 290004119 | 290007709 | 1.78 | 51.2 | Curative (C) | 2015-11-23 | 2015-12-20 | Capecitabine | N | Y | 290020604 | CAPECITABINE + RT |
| 290004120 | 290008174 | 1.66 | 73.1 | Neo-adjuvant (N) | 2018-11-30 | 2018-12-01 | Irinotecan + Modified De Gramont | 02 | N | 290020605 | EOX |
| 290004121 | 290003049 | 1.51 | 71 | Palliative (P) | 2016-05-10 | 2016-05-17 | Irinotecan | N | N | 290020607 | CARBOPLATIN + CETUXIMAB |
| 290004122 | 290003050 | 1.51 | 71.2 | Palliative (P) | 2016-09-25 | 2016-10-13 | EOX | 2 | N | 290020608 | CAPECITABINE + RT |
| 290004123 | 290003051 | 1.74 | 93.7 | Palliative (P) | 2016-10-07 | 2016-10-12 | Fluorouracil + Folinic Acid Weekly | N | N | 290020609 | CISPLATIN + FLUOROURACIL |
| 290004124 | 290003052 | 1.69 | 69.8 | Palliative (P) | 2016-08-13 | 2016-08-13 | Ipilimumab | 2 | N | 290020610 | CAPECITABINE + RT |
| 290004125 | 290003053 | 1.67 | 62.7 | Neo-adjuvant (N) | null | 2017-03-28 | CETUXIMAB + RT | N | Y | 290020612 | CAPECITABINE + RT |
| 290004126 | 290003054 | 1.78 | 56.5 | null | 2017-09-21 | 2017-10-11 | Everolimus 10mg | N | Y | 290020613 | CISPLATIN + FLUOROURACIL |
| 290004127 | 290003054 | 1.51 | null | Palliative (P) | 2016-06-14 | 2016-06-30 | Dacarbazine | N | N | 290020613 | CISPLATIN + FLUOROURACIL |
| 290004128 | 290003055 | 1.64 | null | Adjuvant (A) | 2017-06-28 | 2017-07-18 | Capecitabine | N | N | 290020615 | CAPECITABINE + RT |
| 290004129 | 290003056 | 1.73 | 0 | Palliative (P) | 2017-05-12 | 2017-05-19 | CETUXIMAB + RT | 02 | null | 290020617 | CISPLATIN + FLUOROURACIL |
| 290004130 | 290003057 | 1.68 | 107.9 | Palliative (P) | null | 2018-04-09 | Bevacizumab + Cape + Oxali 14day | null | null | 290020618 | CARBO + FLUOROURACIL |
| 290004131 | 290003058 | null | null | Palliative (P) | 2015-01-02 | 2015-01-16 | Cetuximab + Irinotecan (Cycle 1) | null | N | 290020620 | CISPLATIN + FLUOROURACIL + RT |
| 290004132 | 290003059 | null | null | null | 2017-07-13 | 2017-07-13 | CETUXIMAB | N | null | 290020622 | INTERFERON |
| 290004133 | 290003060 | 1.68 | null | Palliative (P) | 2016-03-18 | 2016-03-18 | CISPLATIN + FLUOROURACIL | N | N | 290020624 | CAPECITABINE + RT |
| 290004134 | 290003061 | 1.47 | 62.8 | Adjuvant (A) | 2015-03-03 | 2015-03-04 | Capecitabine + Streptozocin | 02 | N | 290020628 | RITUXIMAB |
| 290004135 | 290003062 | 0 | 71.3 | Palliative (P) | 2015-11-26 | 2015-12-15 | Capecitabine | 02 | N | 290020629 | CARBO + FLUOROURACIL |
| 290004136 | 290003063 | 1.65 | 0 | Palliative (P) | 2018-01-18 | 2018-01-18 | TCF | 02 | N | 290020630 | NOT MATCHED |
| 290004137 | 290003063 | null | 66.4 | Adjuvant (A) | 2014-05-25 | 2014-06-15 | Capecitabine 35days + RT | N | N | 290020630 | PLATO TRIAL |
| 290004138 | 290003063 | null | 61.6 | Palliative (P) | 2017-04-11 | 2017-04-28 | Cisplatin + Etoposide (3 day) | N | N | 290020630 | CAPECITABINE |
| 290004139 | 290003064 | 1.68 | 44 | null | 2018-02-07 | 2018-02-07 | Bevacizumab + Cape + Oxali 21day | N | N | 290020636 | CARBO + FLUOROURACIL |
| 290004140 | 290006420 | 1.54 | null | Curative (C) | 2015-10-07 | 2015-10-07 | Capecitabine | 02 | Y | 290020637 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |